Skip to main content
. 2019 Mar 12;7(4):801–805. doi: 10.1002/ccr3.2102

Figure 2.

Figure 2

Clinical course of our patient. ALT, alanine aminotransferase (IU/L); AST, aspartate aminotransferase (IU/L); CRP, C‐reactive protein (mg/dL); CTRX, intravenous ceftriaxone; FDP, fibrin degradation products (µg/mL); Hb, hemoglobin; LDH, lactate dehydrogenase (IU/L); MEPM, intravenous meropenem; PLT, platelet count (×104/mm3); WBC, white blood cell count (/mm3)